That’s a wrap on #GastroDiet2025 @MonashFODMAP 🇮🇹 Loved presenting on the role of dietitians as leaders of GI services and our roundtable session on weight loss strategies with A/Prof @psumithran1

Priya Sumithran & Louise A Baur comment on: Growing evidence for semaglutide efficacy in Asian adults with obesity https://t.co/ikLxxl2kaI #obesity

At the #OW2024 opening last night, @BrocqSarah totally nailed it: “We offer acute treatment for a chronic condition and that simply does not work.” https://t.co/kjf4hmEh6a

Obesity is a growing global epidemic with major health consequences. Bariatric surgery is the most effective treatment, with progress in the development of pharmacological agents. However, all obesity treatments have been underutilised. Find out more: https://t.co/97Ccllbwfe

GLP-1 for Treating Obesity: 2024 Lasker-DeBakey Clinical Medical Research Award

Obesity is a growing epidemic with major health consequences. "It is crucial to enhance prevention efforts and explore effective interventions that are scalable irrespective of sociodemographic considerations", say authors of a Seminar. Read this & more: https://t.co/Cqb1eicHQ1

Published today in @TheLancet Management of #obesity follows the same principles as management of other CHRONIC conditions. https://t.co/aBqjLI6Rv5

Newsflash. 99% of all chronic disorders relapse after stopping medical therapy

#SELECTstudy is out in @NEJM and at #AHA23 today. It's pretty much unmistakable now that obesity treatment can help people lead longer, healthier lives. Time has come to tear down the barriers to equitable access to care. HT: @ObesityAction @MarsApovian https://t.co/h2u29YatQ1

Are you undergoing #bariatric (weight-loss) surgery or hiatus hernia repair in Australia? Participate in @Bariatric_CQR #research to understand how surgery affects your #mood, #qualityoflife, and eating behaviour. Follow the link to learn more: https://t.co/TWgpeHMMts

"The impact of obesity on morbidity, mortality, quality of life, and health-care costs is immense—we cannot afford not to treat it from a health, economic, or ethical perspective." New Comment—Obesity drug shortages are symptomatic of wider malaise:

Obesity drug shortages are symptomatic of wider malaise - @psumithran1 @rvcohen @FrancisFinucane

Yes, we're making progress in overcoming #obesity. But no, we're not yet ready to take it seriously as a #ChronicDisease. New insight from @RVCohen @PSumithran @FrancisFinucane @IanPatton55 @xramossalas et al. https://t.co/SbTPXDWUvB

https://t.co/0Zk8SrgxW6

https://t.co/yRvD2PmJIa How do we get across the simple idea that if people are real experts in an area they will be asked to advise industry?

Her work paved the way for blockbuster obesity drugs. Now, she’s fighting for recognition | Science | AAAS

We can all benefit from having someone who believes in us, and we can each be that person for someone else.

Is Metabolic Surgery Having an Identity Crisis? • The answer is “no.” • Anti-obesity Meds (AOMs) are very effective now (>20% WL) • Head-to-head studies AOM vs Surgery have not yet been conducted • Response to AOMs treatment varies: - With DM can have less response (10%WL) -

It is not hard to find systems-wide bias against people living with #obesity They are judged unfairly, and held to a different standard relative to many other people with non-communicable diseases. This bias causes further harm to their health and is widespread, even among HCPs

No magic bullets